Latest Breaking News On - Therapeutics announces - Page 2 : comparemela.com

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients

Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to implement a number of protocol amendments to its ongoing clinical trial for HT-001, which.

Robb knieDrug administrationLr advisorsHoth therapeutics incExchange commissionPrnewswire hoth therapeutics incTherapeutics announcesTreat severely illEpidermal growth factor receptor inhibitorsInvestigational new drug applicationHoth therapeuticChief executive officerHoth therapeuticsPrivate securities litigation reform actAnnual report

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry s First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry s First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South san franciscoUnited statesSan franciscoCemacabtagene ansegedleucel cemaAlex herreraPolatuzumab vedotinChristine cassianoDavid changZachary robertsDivision of lymphomaCorporate affairs brand strategyAllogene therapeutics incDepartment of hematology hematopoietic cell transplantationCompany to focus manufacturing in cell forgeDrug administrationResearch development

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Garry neilChris brinzeyChristopher sullivanCelldex therapeuticsScience technology at johnsonPfizer incBoard of arena pharmaceuticals incAvalo therapeutics incTherapeutics announcesEastern timeNasdaq capital marketNasdaq capitalChief executive officerGroup presidentArena pharmaceuticals incPrivate securities litigation reform act

Elicio Therapeutics Announces $7 0 Million Private Placement Financing

Elicio Therapeutics Announces $7 0 Million Private Placement Financing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesHeather divecchiaElicio therapeutics incLifesci communicationsSecurities exchangeExchange commissionTherapeutics announcesPrivate placementSecurities actResale sharesSecurities exchange actPrivate securities litigation reform actCurrent reportQuarterly reports

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNeurogene incSecurities exchangeExchange commission onNeoleukin therapeutics incEquiniti trust companyTherapeutics announcesEastern timeNasdaq global marketNasdaq globalNeoleukin therapeuticsSecurities actSecurities exchange actNasdaq capital marketQuarterly reportExchange commission